Highlights and Quick Summary
- Annual 3Y Operating CF Growth (per Share) for 2022 was 0.0% (a -100.0% decrease from previous year)
- Annual 3Y Operating CF Growth (per Share) for 2021 was 93.04% (a 246.0% increase from previous year)
- Annual 3Y Operating CF Growth (per Share) for 2020 was 26.89% (a -31.12% decrease from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Operating CF Growth (per Share) of Emergent Biosolutions Inc.
Most recent 3Y Operating CF Growth (per Share)of EBS including historical data for past 10 years.Interactive Chart of 3Y Operating CF Growth (per Share) of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. 3Y Operating CF Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | 0.0% |
| 2021 | – | – | – | – | 93.04% |
| 2020 | – | – | – | – | 26.89% |
| 2019 | – | – | – | – | 39.04% |
| 2018 | – | – | – | – | -8.85% |
| 2017 | – | – | – | – | 18.29% |
| 2016 | – | – | – | – | -20.26% |
| 2015 | – | – | – | – | 0.08% |
| 2014 | – | – | – | – | 106.47% |
| 2013 | – | – | – | – | 0.0% |
| 2012 | – | – | – | – | -0.08% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic